Fructosamine: structure, analysis, and clinical usefulness.
about
Salivary markers of oxidative stress in oral diseasesIndicators of glycemic control in patients with gestational diabetes mellitus and pregnant women with diabetes mellitusGlycated albumin is the preferred marker for assessing glycaemic control in advanced chronic kidney diseaseUpdates on the management of diabetes in dialysis patientsVariables involved in the discordance between HbA1c and fructosamine: the glycation gap revisitedEngineered silybin nanoparticles educe efficient control in experimental diabetesGlycation of nail proteins: from basic biochemical findings to a representative marker for diabetic glycation-associated target organ damageAssociation of fructosamine to indices of dyslipidemia in older adults with type 2 diabetes.Association of glycated albumin with the presence of carotid plaque in patients with type 2 diabetes.Serum glycated albumin as a new glycemic marker in pediatric diabetesMetrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.Comparison of modification sites formed on human serum albumin at various stages of glycationIn vitro galactation of human serum albumin: analysis of the protein's galactation sites by mass spectrometry.The effect of alpha-linolenic acid on glycemic control in individuals with type 2 diabetes: A systematic review and meta-analysis of randomized controlled clinical trials.The ratio of estimated average glucose to fasting plasma glucose level is superior to glycated albumin, hemoglobin A1c, fructosamine, and GA/A1c ratio for assessing β-cell function in childhood diabetesImpact of initial active engagement in self-monitoring with a telemonitoring device on glycemic control among patients with type 2 diabetesA High-Fructose-High-Coconut Oil Diet Induces Dysregulating Expressions of Hippocampal Leptin and Stearoyl-CoA Desaturase, and Spatial Memory Deficits in Rats.Study of the effect of total serum protein and albumin concentrations on canine fructosamine concentrationObesity in rhesus and cynomolgus macaques: a comparative review of the condition and its implications for researchComparative associations of diabetes risk factors with five measures of hyperglycemia.Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.Amadori albumin in diabetic nephropathyAntidiabetic and antioxidant effects and phytochemicals of mulberry fruit (Morus alba L.) polyphenol enhanced extract.Calcineurin (CN) activation promotes apoptosis of glomerular podocytes both in vitro and in vivoEmerging applications of metabolomic and genomic profiling in diabetic clinical medicine.The Shepherds' Tale: A Genome-Wide Study across 9 Dog Breeds Implicates Two Loci in the Regulation of Fructosamine Serum Concentration in Belgian ShepherdsOxidized LDL and Fructosamine Associated with Severity of Coronary Artery Atherosclerosis in Insulin Resistant Pigs Fed a High Fat/High NaCl Diet.Influence of glycemic control on gain in VO2 peak, in patients with type 2 diabetes enrolled in cardiac rehabilitation after an acute coronary syndrome. The prospective DARE studySalivary protein glycosylation as a noninvasive biomarker for assessment of glycemia.Postmortem diagnosis of diabetes mellitus and its complications.Association between Serum Fructosamine and Kidney Function in Nondiabetic Individuals without Chronic Kidney DiseaseThe roles of glycated albumin as intermediate glycation index and pathogenic protein.Fructosamine and Hemoglobin A1c Correlations in HIV-Infected Adults in Routine Clinical Care: Impact of Anemia and Albumin LevelsRational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markersAlternative markers of hyperglycemia and risk of diabetes.Hemoglobin A1c in diabetes: panacea or pointless?Safety and efficacy of extended-release niacin for the treatment of dyslipidaemia in patients with HIV infection: AIDS Clinical Trials Group Study A5148.Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia.Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose.Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients.
P2860
Q26779292-6981C064-F378-4635-828A-64CBB502D57BQ26799252-F6B1E06B-5DC6-492C-B282-4F3B6DC41E0DQ26827458-F2DEFC1E-8773-4037-BA84-2E6C823EB98AQ27024782-7EAFA246-9CC1-4A21-A6AE-34557566BCC7Q28533840-81A5DF36-2EAC-4801-932B-E92DA8458568Q28540351-106DAFB9-F75F-4CB7-9EE2-0C0A5C099E9FQ28544417-632C5071-CA3E-4017-8DD4-8A5319EBFB18Q30408552-0BD6B797-8321-4CFB-969F-048F80074F2DQ33607781-57898E3C-2B7D-44A3-951E-EF92EFC3D634Q33635293-C21FE8DD-74F8-453A-87D0-3D145B3F22C7Q33727475-502D0400-D09A-418A-BD42-8D2DEB6E962CQ33733746-E89FB9DF-6104-454B-9DCB-238E717CF21DQ33757191-6A590B3B-93B1-4AD0-951B-F93D88F75C03Q33760445-BED014AF-0F15-48D2-8AD5-1CC7290654D7Q33809715-E57E5EF2-DBDA-4312-8398-22B731567089Q33819061-3CA34D16-EA0F-4E25-935E-75D29E2C84C2Q33852124-A9F0156D-C073-4D91-94CF-A243E42763A2Q33923564-80EA2660-E8A3-4A86-83BE-41E7DDC64FCDQ34254063-BCB9C708-833A-4288-9833-6DD53969FA79Q34419206-485C4B2B-15F7-416A-A6A1-F0202FCBDAF6Q34425731-2AFC75A6-FDF6-4249-83EE-56C6A285D65CQ34878346-258EAC6A-A57B-42C4-B0A7-E62DE44B55C5Q34923661-C8220D1F-5CF5-497E-970C-2D21B1A9BFB0Q35135695-791531DE-D81E-4C37-9B89-7A18635D522DQ35563714-A41F3F6A-FFB4-4C96-943A-CB942523A883Q35602801-231737FD-8CCD-4FE5-B8B5-22B8764FB18FQ35684097-AB49627D-E3E9-421A-9E12-EC98CE01B58CQ35685463-F9F2EC67-8150-4DF2-A154-2129FFCA717FQ35830450-9D575557-D83F-48E6-B814-D6A9BAEA626FQ35847872-C61550CD-B28D-4CF3-B229-E9F20A747802Q35871458-1BC28C3C-CC92-4886-960A-6BEE4E523D90Q35911117-1077CFF8-C905-4D9C-8A4E-CC75A3B5BFF4Q35930866-7CD31C42-EF49-4CEC-8DD4-85F34EBD410EQ36234192-EB195516-7CF2-4FAD-B4B1-126369289EA7Q36334628-773000AA-CD44-4C63-89D7-233442F228DAQ36477316-BBAB598C-9E3C-4116-9ABE-03140738CFEDQ36528526-C9F69DCA-C8EE-4DC3-8BE0-767D95C9F22AQ36726169-6FAEEB75-39D6-4412-9165-337639135885Q36838473-50A75279-C8E0-4FA5-98C5-8EC7B0FE5BF5Q36868213-D0488E19-3DF6-4788-96D6-16CF87D32A8D
P2860
Fructosamine: structure, analysis, and clinical usefulness.
description
1987 nî lūn-bûn
@nan
1987 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Fructosamine: structure, analysis, and clinical usefulness.
@ast
Fructosamine: structure, analysis, and clinical usefulness.
@en
Fructosamine: structure, analysis, and clinical usefulness.
@nl
type
label
Fructosamine: structure, analysis, and clinical usefulness.
@ast
Fructosamine: structure, analysis, and clinical usefulness.
@en
Fructosamine: structure, analysis, and clinical usefulness.
@nl
prefLabel
Fructosamine: structure, analysis, and clinical usefulness.
@ast
Fructosamine: structure, analysis, and clinical usefulness.
@en
Fructosamine: structure, analysis, and clinical usefulness.
@nl
P1433
P1476
Fructosamine: structure, analysis, and clinical usefulness
@en
P2093
D A Armbruster
P304
P407
P577
1987-12-01T00:00:00Z